Search research articles
Contact Us
Filters
Showing results (251-260 of 288) with videos related to
Page
of 29
Sort By:
Seminars in Hematology
|
April 26, 2023
Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management
E Terpos, A R Branagan, R García-Sanz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group
M A Dimopoulos, C Bakoyannis, V Georgoulias, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 7, 2021
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>
M A Dimopoulos, P Moreau, E Terpos, et al.
Blood Cancer Journal
|
June 17, 2017
Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit
M A Dimopoulos, M Roussou, M Gavriatopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group
A Bamias, G Aravantinos, C Deliveliotis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2022
Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]
M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2021
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]
M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Moreau, J San Miguel, P Sonneveld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group
J R Berenson, A Lichtenstein, L Porter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2003
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma
M A Dimopoulos, A Pouli, K Zervas, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 288) with videos related to
Sort By:
Page
of 29
Seminars in Hematology
|
April 26, 2023
Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management
E Terpos, A R Branagan, R García-Sanz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group
M A Dimopoulos, C Bakoyannis, V Georgoulias, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 7, 2021
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>
M A Dimopoulos, P Moreau, E Terpos, et al.
Blood Cancer Journal
|
June 17, 2017
Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit
M A Dimopoulos, M Roussou, M Gavriatopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group
A Bamias, G Aravantinos, C Deliveliotis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2022
Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]
M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2021
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]
M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Moreau, J San Miguel, P Sonneveld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group
J R Berenson, A Lichtenstein, L Porter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2003
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma
M A Dimopoulos, A Pouli, K Zervas, et al.
Page
of 29